Related Experiment Video
Updated: Jun 14, 2025

Laser Microirradiation to Study In Vivo Cellular Responses to Simple and Complex DNA Damage
Published on: January 31, 2018
PARP1-TRIM44-MRN loop dictates the response to PARP inhibitors
Yonghyeon Kim1, Sunwoo Min1,2, Soyeon Kim3
1Department of Biochemistry, Ajou University School of Medicine, Suwon 16499, Republic of Korea.
Abstract:
PARP inhibitors (PARPi) show selective efficacy in tumors with homologous recombination repair (HRR)-defects but the activation mechanism of HRR pathway in PARPi-treated cells remains enigmatic. To unveil it, we searched for the mediator bridging PARP1 to ATM pathways by screening 211 human ubiquitin-related proteins. We discovered TRIM44 as a crucial mediator that recruits the MRN complex to damaged chromatin, independent of PARP1 activity. TRIM44 binds PARP1 and regulates the ubiquitination-PARylation balance of PARP1, which facilitates timely recruitment of the MRN complex for DSB repair. Upon exposure to PARPi, TRIM44 shifts its binding from PARP1 to the MRN complex via its ZnF UBP domain. Knockdown of TRIM44 in cells significantly enhances the sensitivity to olaparib and overcomes the resistance to olaparib induced by 53BP1 deficiency. These observations emphasize the central role of TRIM44 in tethering PARP1 to the ATM-mediated repair pathway. Suppression of TRIM44 may enhance PARPi effectiveness and broaden their use even to HR-proficient tumors.
Insights
Researchers identified TRIM44 as a key mediator in DNA repair. This protein links PARP1 to the ATM pathway, influencing homologous recombination repair (HRR) and potentially enhancing PARP inhibitor effectiveness.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- Poly (ADP-ribose) polymerase inhibitors (PARPi) demonstrate efficacy in tumors with homologous recombination repair (HRR) defects.
- The precise mechanism activating the HRR pathway in PARPi-treated cells remains unclear.
Purpose of the Study:
- To identify the mediator connecting PARP1 and ATM pathways in DNA repair.
- To elucidate the role of TRIM44 in homologous recombination repair and PARPi response.
Main Methods:
- Screening of 211 human ubiquitin-related proteins to identify key mediators.
- Investigating the interaction of TRIM44 with PARP1 and the MRN complex.
- Assessing the impact of TRIM44 knockdown on cellular sensitivity to olaparib.
Main Results:
- TRIM44 was identified as a crucial mediator that recruits the MRN complex to damaged chromatin, independent of PARP1 activity.
- TRIM44 regulates the ubiquitination-PARylation balance of PARP1, facilitating MRN complex recruitment for double-strand break (DSB) repair.
- TRIM44 knockdown increased sensitivity to olaparib and overcame resistance associated with 53BP1 deficiency.
Conclusions:
- TRIM44 plays a central role in linking PARP1 to the ATM-mediated DNA repair pathway.
- Targeting TRIM44 could enhance PARPi efficacy and potentially expand their application to HR-proficient tumors.
More Related Videos
Related Concept Videos
Restarting Stalled Replication Forks
Long-patch Base Excision Repair
DNA Damage can Stall the Cell Cycle
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Base Excision Repair
The first step of...
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...

